Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Khetsuriani, Nino; Tishkova, Faina; Jabirov, Shamsidin; Wannemuehler, Kathleen A.; Kamili, Saleem; Pirova, Zulfiya; Mosina, Liudmila; Gavrilin, Eugene; Ursu, Pavel; Drobeniuc, Jan

doi:10.1016/j.vaccine.2015.05.092

Record: found
Abstract: found
Article: not found

Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Author(s): Nino Khetsuriani ¹ , Faina Tishkova ² , Shamsidin Jabirov ² , Kathleen Wannemuehler ³ , Saleem Kamili ³ , Zulfiya Pirova ⁴ , Liudmila Mosina ⁵ , Eugene Gavrilin ⁵ , Pavel Ursu ⁴ , Jan Drobeniuc ³

Publication date (Electronic): Jul 31 2015

Journal: Vaccine

Keywords: Hepatitis B immunization, Hepatitis B vaccine impact, Hepatitis B virus infections, Prevalence of HBsAg, Tajikistan, WHO European Region

Read this article at

ScienceOpenPublisher PMC

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine (HepB3) since 2004. However, the impact of vaccine introduction has not been assessed.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Vaccine

Title: Vaccine

ISSN (Electronic): 1873-2518

ISSN (Print): 0264-410X

Publication date (Electronic): Jul 31 2015

Volume: 33

Issue: 32

Affiliations

[1 ] Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: nck7@cdc.gov.

[2 ] Ministry of Health of Tajikistan, Dushanbe, Tajikistan.

[3 ] Centers for Disease Control and Prevention, Atlanta, GA, USA.

[4 ] World Health Organization (WHO) Country Office, Dushanbe, Tajikistan.

[5 ] WHO Regional Office for Europe, Copenhagen, Denmark.

Article

Publisher Item ID: S0264-410X(15)00766-5 Mid ID: HHSPA746065

DOI: 10.1016/j.vaccine.2015.05.092

PMC ID: 4693601

PubMed ID: 26072015

SO-VID: caf4194a-8c02-4889-a09b-506647d563e8

History

Keywords: Hepatitis B immunization,Hepatitis B vaccine impact,Hepatitis B virus infections,Prevalence of HBsAg,Tajikistan,WHO European Region

Data availability:

Keywords: Hepatitis B immunization, Hepatitis B vaccine impact, Hepatitis B virus infections, Prevalence of HBsAg, Tajikistan, WHO European Region

Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Read this article at

Abstract

Related collections

Malaria vaccine development

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 85

Cited by 9